[
    [
        {
            "time": "2021-03-26",
            "original_text": "Vaccination distribution is ‘a race against time’ as variants spread: Doctor",
            "features": {
                "keywords": [
                    "vaccination",
                    "distribution",
                    "variants",
                    "spread"
                ],
                "sentiment_score": -0.2,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "Vaccination distribution is ‘a race against time’ as variants spread: Doctor",
                "Correlation": 5,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-03-26",
            "original_text": "Rutgers University to require COVID-19 vaccinations this fall",
            "features": {
                "keywords": [
                    "Rutgers",
                    "university",
                    "require",
                    "COVID-19",
                    "vaccinations"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "education",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "Rutgers University to require COVID-19 vaccinations this fall",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-03-26",
            "original_text": "U.S. to Have Supply of 240 Million COVID Shots by Next Week",
            "features": {
                "keywords": [
                    "U.S.",
                    "supply",
                    "COVID",
                    "shots"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "U.S. to Have Supply of 240 Million COVID Shots by Next Week",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-03-26",
            "original_text": "BioNTech's Marburg facility gets EMA approval, boosting COVID-19 vaccine production capacity by a billion doses a year",
            "features": {
                "keywords": [
                    "BioNTech",
                    "EMA",
                    "approval",
                    "vaccine",
                    "production"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "BioNTech's Marburg facility gets EMA approval, boosting COVID-19 vaccine production capacity by a billion doses a year",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-03-26",
            "original_text": "Pfizer (PFE) Gets Unfavorable Votes from FDA Panel for Tanezumab",
            "features": {
                "keywords": [
                    "Pfizer",
                    "FDA",
                    "Tanezumab",
                    "unfavorable"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Pfizer (PFE) Gets Unfavorable Votes from FDA Panel for Tanezumab",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-03-26",
            "original_text": "UPDATE 3-EU clears vaccine sites to boost inoculation drive",
            "features": {
                "keywords": [
                    "EU",
                    "clears",
                    "vaccine",
                    "sites",
                    "inoculation"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "UPDATE 3-EU clears vaccine sites to boost inoculation drive",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-03-26",
            "original_text": "WeWork Is Back — With a SPAC",
            "features": {
                "keywords": [
                    "WeWork",
                    "SPAC"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "real estate"
                ],
                "causal_factor": "false",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "WeWork Is Back — With a SPAC",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-03-26",
            "original_text": "Astellas Receives Positive CHMP Opinion for XTANDI™ (enzalutamide) for Patients with Metastatic Hormone-Sensitive Prostate Cancer",
            "features": {
                "keywords": [
                    "Astellas",
                    "CHMP",
                    "XTANDI",
                    "prostate cancer"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "Astellas Receives Positive CHMP Opinion for XTANDI™ (enzalutamide) for Patients with Metastatic Hormone-Sensitive Prostate Cancer",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-03-26",
            "original_text": "UK study finds strong immune responses from one dose of Pfizer COVID-19 shot",
            "features": {
                "keywords": [
                    "UK",
                    "study",
                    "immune",
                    "responses",
                    "Pfizer",
                    "shot"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "UK study finds strong immune responses from one dose of Pfizer COVID-19 shot",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-03-26",
            "original_text": "FDA Advisory Panel Says Risks Outweigh Benefits of Pfizer and Lilly’s Pain Drug",
            "features": {
                "keywords": [
                    "FDA",
                    "Advisory",
                    "Panel",
                    "Risks",
                    "Benefits",
                    "Pfizer",
                    "Lilly",
                    "Pain Drug"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "FDA Advisory Panel Says Risks Outweigh Benefits of Pfizer and Lilly’s Pain Drug",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-03-26",
            "original_text": "The Zacks Analyst Blog Highlights: Pfizer, UnitedHealth Group, Centene Corp, Cigna Corp and AMN Healthcare Services",
            "features": {
                "keywords": [
                    "Zacks",
                    "Analyst",
                    "Blog",
                    "Pfizer",
                    "UnitedHealth",
                    "Group",
                    "Centene",
                    "Corp",
                    "Cigna",
                    "Corp",
                    "AMN",
                    "Healthcare",
                    "Services"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "insurance"
                ],
                "causal_factor": "false",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "The Zacks Analyst Blog Highlights: Pfizer, UnitedHealth Group, Centene Corp, Cigna Corp and AMN Healthcare Services",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-03-26",
            "original_text": "Got $1,400? 3 COVID Stocks to Buy and Hold for the Long Term",
            "features": {
                "keywords": [
                    "$1,400",
                    "COVID",
                    "stocks",
                    "buy",
                    "hold",
                    "long term"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Got $1,400? 3 COVID Stocks to Buy and Hold for the Long Term",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-03-26",
            "original_text": "Pfizer And Eli Lilly's Osteoarthritis Drug Rejected By FDA Panel As Too Risky",
            "features": {
                "keywords": [
                    "Pfizer",
                    "Eli Lilly",
                    "Osteoarthritis",
                    "Drug",
                    "Rejected",
                    "FDA",
                    "Panel",
                    "Risky"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Pfizer And Eli Lilly's Osteoarthritis Drug Rejected By FDA Panel As Too Risky",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-03-26",
            "original_text": "In Key Milestone, Pfizer Begins Testing COVID-19 Vaccine In Children",
            "features": {
                "keywords": [
                    "Pfizer",
                    "Milestone",
                    "Testing",
                    "COVID-19",
                    "Vaccine",
                    "Children"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "In Key Milestone, Pfizer Begins Testing COVID-19 Vaccine In Children",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-03-26",
            "original_text": "Vaccines require investors who are long-term greedy",
            "features": {
                "keywords": [
                    "Vaccines",
                    "investors",
                    "long-term",
                    "greedy"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Vaccines require investors who are long-term greedy",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-03-26",
            "original_text": "EU regulator approves contested Dutch vaccine production site",
            "features": {
                "keywords": [
                    "EU",
                    "regulator",
                    "approves",
                    "contested",
                    "Dutch",
                    "vaccine",
                    "production",
                    "site"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "EU regulator approves contested Dutch vaccine production site",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-03-26",
            "original_text": "Vaccines required investors who were long-term greedy",
            "features": {
                "keywords": [
                    "Vaccines",
                    "required",
                    "investors",
                    "long-term",
                    "greedy"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Vaccines required investors who were long-term greedy",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        }
    ]
]